[EQUITIES] ‘Green Cross still in spending cycle’
Oct. 28, 2016
[THE INVESTOR] Green Cross failed to meet market expectations with 34.6 billion won (US$30.20 million) operating profit and 327.6 billion won revenue in the third quarter, said Korea Investment and Securities on Oct. 28, lowering its target price to 206,000 won from 232,000 won.Its revenue was boosted by the introduction of new products but sales from flu vaccine, which has higher margin, was deferred and research and development cost increased by over 40 percent to 110 billion won, bringing dow